Literature DB >> 208489

Latent herpes simplex virus in ganglia of mice after primary infection and reinoculation at a distant site.

R J Klein, A E Friedman-Kien, E Brady.   

Abstract

Herpes simplex virus (HSV)-infected hairless mice with evidence of latent infection in spinal ganglia did not develop latent HSV infections in trigeminal ganglia upon reinfection in the oro-facial area. HSV-infected and PAA-treated mice without evidence of latent HSV infection in spinal ganglia were resistant to reinfection in the lumbar region, but not to that performed in the oro-facial area.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 208489     DOI: 10.1007/bf01315677

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  8 in total

1.  Latent infection of sensory ganglia with herpes simplex virus: efficacy of immunization.

Authors:  R W Price; M A Walz; C Wohlenberg; A L Notkins
Journal:  Science       Date:  1975-05-30       Impact factor: 47.728

2.  Efficacy of phosphonoacetic acid on herpes simplex virus infection of sensory ganglia.

Authors:  C R Wohlenberg; M A Walz; A L Notkins
Journal:  Infect Immun       Date:  1976-05       Impact factor: 3.441

3.  Phosphonoacetic acid-resistant herpes simplex virus infection in hairless mice.

Authors:  R J Klein; A E Friedman-Kien
Journal:  Antimicrob Agents Chemother       Date:  1975-03       Impact factor: 5.191

4.  The role of type specific and cross reacting structural antigens in the neutralization of herpes simplex virus types 1 and 2.

Authors:  C Sim; D H Watson
Journal:  J Gen Virol       Date:  1973-05       Impact factor: 3.891

Review 5.  Infection with herpes-simplex viruses 1 and 2. 3.

Authors:  A J Nahmias; B Roizman
Journal:  N Engl J Med       Date:  1973-10-11       Impact factor: 91.245

6.  Immune response and latent infection after topical treatment of herpes simplex virus infection in hairless mice.

Authors:  R J Klein; A E Friedman-Kien; A A Fondak; E Buimovici-Klein
Journal:  Infect Immun       Date:  1977-06       Impact factor: 3.441

7.  Efficacy of herpes simplex virus type 1 immunization in protecting against acute and latent infection by herpes simplex virus type 2 in mice.

Authors:  R R McKendall
Journal:  Infect Immun       Date:  1977-05       Impact factor: 3.441

8.  Relative concentrations in human sera of antibodies to cross-reacting and specific antigens of Herpes simplex virus types 1 and 2.

Authors:  H McClung; P Seth; W E Rawls
Journal:  Am J Epidemiol       Date:  1976-08       Impact factor: 4.897

  8 in total
  10 in total

Review 1.  The pathogenesis of acute, latent and recurrent herpes simplex virus infections.

Authors:  R J Klein
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

2.  Immune responses in mice against herpes simplex virus: mechanisms of protection against facial and ganglionic infections.

Authors:  H J Zweerink; D Martinez; R J Lynch; L W Stanton
Journal:  Infect Immun       Date:  1981-01       Impact factor: 3.441

3.  The influence of different modes of immunization on the experimental genital herpes simplex virus infection of mice.

Authors:  K E Schneweis; J Gruber; J Hilfenhaus; A Möslein; M Kayser; M H Wolff
Journal:  Med Microbiol Immunol       Date:  1981       Impact factor: 3.402

4.  Latent herpes simplex virus infections in sensory ganglia of hairless mice prevented by acycloguanosine.

Authors:  R J Klein; A E Friedman-Kien; E DeStefano
Journal:  Antimicrob Agents Chemother       Date:  1979-05       Impact factor: 5.191

5.  Heterotypic and homotypic re-inoculation of mice already latently infected with herpes simplex virus type 1.

Authors:  D L Yirrell; W A Blyth; T J Hill; C E Rogers
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

6.  Correlation between precolonization of trigeminal ganglia by attenuated strains of pseudorabies virus and resistance to wild-type virus latency.

Authors:  L M Schang; G F Kutish; F A Osorio
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

7.  Experimental skin infection with an acyclovir resistant herpes simplex virus mutant: response to antiviral treatment and protection against reinfection.

Authors:  R J Klein; E DeStefano; E Brady; A E Friedman-Kien
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

Review 8.  Herpes simplex virus as a tool to define the role of complement in the immune response to peripheral infection.

Authors:  Mark A Brockman; David M Knipe
Journal:  Vaccine       Date:  2008-12-30       Impact factor: 3.641

9.  Pathogenesis of experimental skin infections induced by drug-resistant herpes simplex virus mutants.

Authors:  R J Klein; A E Friedman-Kien; E DeStefano
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441

10.  Model of vaccine efficacy against HSV-2 superinfection of HSV-1 seropositive mice demonstrates protection by antibodies mediating cellular cytotoxicity.

Authors:  Clare Burn Aschner; David M Knipe; Betsy C Herold
Journal:  NPJ Vaccines       Date:  2020-05-07       Impact factor: 9.399

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.